Colistin: an Antibiotic and Its Role in Multiresistant Gram-negative Infections

Increasing number of infection cases caused by multiresistant Gram-negative bacteria or multidrug resistant organism (MDRO) has become a major problem worldwide since there have been a lot of resistance to many classes of antibiotics. Mutant isolates such as fluoroquinolone-resistant and β-lactamase...

Full description

Saved in:
Bibliographic Details
Main Authors: Tonny Loho, Anti Dharmayanti
Format: Article
Language:English
Published: Interna Publishing 2016-05-01
Series:Acta Medica Indonesiana
Online Access:https://mail.actamedindones.org/index.php/ijim/article/view/52
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839616942483177472
author Tonny Loho
Anti Dharmayanti
author_facet Tonny Loho
Anti Dharmayanti
author_sort Tonny Loho
collection DOAJ
description Increasing number of infection cases caused by multiresistant Gram-negative bacteria or multidrug resistant organism (MDRO) has become a major problem worldwide since there have been a lot of resistance to many classes of antibiotics. Mutant isolates such as fluoroquinolone-resistant and β-lactamase-resistant bacteria have been commonly found, particularly in intensive care unit (ICU). During the last two decades, there has been no study of developing antibiotics in search of discovering new type of antibiotics; meanwhile, the resistance of Gram-negative bacteria or MDRO to antibiotics is increasing. Colistin or polymyxin E is an old antibiotic, which has been used since 1959 for treating infection caused by Gram-negative MDRO. It was revealed that colistin has side effects of nephrotoxicity and neurotoxicity; therefore, the use of this antibiotic was stopped and it was replaced by other antibiotics which were effective and were considered safer at that time. There is an increasing number of infections with multi-resistant Gram-negative (MDRO) against the available antibiotics and the availability of alternative antibiotics has not been satisfying; therefore, microbiologists are searching back to the old option, which has been proven to be effective against multi-resistant Gram-negative bacteria, the old antibiotic that has been long forgotten, i.e. colistin, as an alternative treatment against Gram-negative MDRO. It is expected that colistin may have essential and reliable role as future antibiotics for treatment of multi-resistant Gram-negative infections and as an alternative of antibiotics that have been available so far. Key words: antibiotics, colistin, Gram-negative, multidrug resistant organism (MDRO).
format Article
id doaj-art-ad2ce71f26a7468f83bafd1a2e6f8a49
institution Matheson Library
issn 0125-9326
2338-2732
language English
publishDate 2016-05-01
publisher Interna Publishing
record_format Article
series Acta Medica Indonesiana
spelling doaj-art-ad2ce71f26a7468f83bafd1a2e6f8a492025-07-25T07:01:38ZengInterna PublishingActa Medica Indonesiana0125-93262338-27322016-05-01472Colistin: an Antibiotic and Its Role in Multiresistant Gram-negative InfectionsTonny Loho0Anti Dharmayanti1Department of Clinical Pathology, Cipto Mangunkusumo Hospital, Jakarta, IndonesiaDepartment of Clinical Pathology, Cipto Mangunkusumo Hospital, Jakarta, Indonesia.Increasing number of infection cases caused by multiresistant Gram-negative bacteria or multidrug resistant organism (MDRO) has become a major problem worldwide since there have been a lot of resistance to many classes of antibiotics. Mutant isolates such as fluoroquinolone-resistant and β-lactamase-resistant bacteria have been commonly found, particularly in intensive care unit (ICU). During the last two decades, there has been no study of developing antibiotics in search of discovering new type of antibiotics; meanwhile, the resistance of Gram-negative bacteria or MDRO to antibiotics is increasing. Colistin or polymyxin E is an old antibiotic, which has been used since 1959 for treating infection caused by Gram-negative MDRO. It was revealed that colistin has side effects of nephrotoxicity and neurotoxicity; therefore, the use of this antibiotic was stopped and it was replaced by other antibiotics which were effective and were considered safer at that time. There is an increasing number of infections with multi-resistant Gram-negative (MDRO) against the available antibiotics and the availability of alternative antibiotics has not been satisfying; therefore, microbiologists are searching back to the old option, which has been proven to be effective against multi-resistant Gram-negative bacteria, the old antibiotic that has been long forgotten, i.e. colistin, as an alternative treatment against Gram-negative MDRO. It is expected that colistin may have essential and reliable role as future antibiotics for treatment of multi-resistant Gram-negative infections and as an alternative of antibiotics that have been available so far. Key words: antibiotics, colistin, Gram-negative, multidrug resistant organism (MDRO).https://mail.actamedindones.org/index.php/ijim/article/view/52
spellingShingle Tonny Loho
Anti Dharmayanti
Colistin: an Antibiotic and Its Role in Multiresistant Gram-negative Infections
Acta Medica Indonesiana
title Colistin: an Antibiotic and Its Role in Multiresistant Gram-negative Infections
title_full Colistin: an Antibiotic and Its Role in Multiresistant Gram-negative Infections
title_fullStr Colistin: an Antibiotic and Its Role in Multiresistant Gram-negative Infections
title_full_unstemmed Colistin: an Antibiotic and Its Role in Multiresistant Gram-negative Infections
title_short Colistin: an Antibiotic and Its Role in Multiresistant Gram-negative Infections
title_sort colistin an antibiotic and its role in multiresistant gram negative infections
url https://mail.actamedindones.org/index.php/ijim/article/view/52
work_keys_str_mv AT tonnyloho colistinanantibioticanditsroleinmultiresistantgramnegativeinfections
AT antidharmayanti colistinanantibioticanditsroleinmultiresistantgramnegativeinfections